SCHEMBL884639

SCHEMBL884639

Cc1ccc(-c2cc(F)ccc2C(Cc2cccnc2)c2cccnc2)cc1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KCNA5 P22460 9/20 0.45
KCNH2 Q12809 6/20 0.45
ALDH1A1 P00352 4/20 0.43
GRM2 Q14416 2/20 0.41
LMNA P02545 2/20 0.39
KDM4E B2RXH2 1/20 0.39
TSHR P16473 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HSD17B10 Q99714 1/20 0.39
CYP3A4 P08684 1/20 0.39
GRIN1 Q05586 1/20 0.37
GRIN2B Q13224 1/20 0.37
CYP11B1 P15538 1/20 0.37
CYP11B2 P19099 1/20 0.37
NPC1 O15118 1/20 0.37
TP53 P04637 1/20 0.37
POLB P06746 1/20 0.37
RAB9A P51151 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5038360 0.93 KCNA5 (0.48) KCNA5KCNH2ALDH1A1GRM2CYP3A4
SCHEMBL5033715 0.90 KCNA5 (0.50) KCNA5KCNH2ALDH1A1GRM2CYP3A4
SCHEMBL884457 0.89 KCNA5 (0.51) KCNA5KCNH2ALDH1A1CYP3A4GRIN1
SCHEMBL884449 0.89 KCNA5 (0.44) KCNA5KCNH2ALDH1A1GRM2CYP3A4
SCHEMBL5032466 0.89 KCNA5 (0.45) KCNA5KCNH2ALDH1A1GRM2LMNA
SCHEMBL884569 0.89 KCNA5 (0.51) KCNA5KCNH2ALDH1A1GRM2CYP11B1
SCHEMBL885069 0.87 KCNA5 (0.56) KCNA5KCNH2ALDH1A1GRM2CYP3A4
SCHEMBL884718 0.85 KCNA5 (0.51) KCNA5KCNH2ALDH1A1GRM2CYP11B1
SCHEMBL884595 0.84 KCNA5 (0.45) KCNA5KCNH2ALDH1A1GRM2CYP11B1
SCHEMBL885203 0.84 KCNA5 (0.42) KCNA5KCNH2ALDH1A1GRM2CYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1940406-A2 POTASSIUM CHANNEL INHIBITORS Merck and Co., Inc. (US) 2008-07-09 EP claimed
WO-2007050348-A2 POTASSIUM CHANNEL INHIBITORS MERCK & CO., INC. (US) 2007-05-03 WO claimed